Delivery of Peptides to the Blood and Brain after Oral Uptake of Quaternary Ammonium Palmitoyl Glycol Chitosan Nanoparticles

被引:68
作者
Lalatsa, A. [1 ]
Garrett, N. L. [2 ]
Ferrarelli, T. [1 ]
Moger, J. [2 ]
Schaetzlein, A. G. [1 ,3 ]
Uchegbu, I. F. [1 ,3 ]
机构
[1] Univ London, UCL Sch Pharm, London WC1N 1AX, England
[2] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England
[3] Nanomerics Ltd, St Albans AL1 1SR, Herts, England
基金
英国工程与自然科学研究理事会;
关键词
chitosan nanoparticles; nanoparticle oral uptake; chitosan amphiphiles; oral peptide delivery; quaternary ammonium palmitoyl glycol chitosan; GCPQ molecular weight; biodistribution; leucine(5)-enkephalin; CARS microscopy; PERFUSION TECHNIQUE; LEUCINE-ENKEPHALIN; MOLECULAR-WEIGHT; ABSORPTION; BIOAVAILABILITY; RAT; DEPOLYMERIZATION; MICE;
D O I
10.1021/mp300068j
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The clinical development of therapeutic peptides has been restricted to peptides for non-CNS diseases and parenteral dosage forms due to the poor permeation of peptides across the gastrointestinal mucosa and the blood-brain barrier. Quaternary ammonium palmitoyl glycol chitosan (GCPQ) nanoparticles facilitate the brain delivery of orally administered peptides such as leucine(5)-enkephalin, and here we examine the mechanism of GCPQ facilitated oral peptide absorption and brain delivery. By analyzing the oral biodistribution of radiolabeled GCPQ nanoparticles, the oral biodistribution of the model peptide leucine(5)-enkephalin and coherent anti-Stokes Raman scattering microscopy tissue images after an oral dose of deuterated GCPQ nanoparticles, we have established a number of facts. Although 85-90% of orally administered GCPQ nanoparticles are not absorbed from the gastrointestinal tract, a peak level of 2-3% of the oral GCPQ dose is detected in the blood 30 min after dosing, and these GCPQ particles appear to transport the peptides to the blood. Additionally, although peptide loaded nanoparticles from low (6 kDa) and high (50 kDa) molecular weight GCPQ are taken up by enterocytes, polymer particles with a polymer molecular weight greater than 6 kDa are required to facilitate peptide delivery to the brain after oral administration. By examining our current and previous data, we conclude that GCPQ particles facilitate oral peptide absorption by protecting the peptide from gastrointestinal degradation, adhering to the mucus to increase the drug gut residence time and transporting GCPQ associated peptide across the enterocytes and to the systemic circulation, enabling the GCPQ stabilized peptide to be transported to the brain. Orally administered GCPQ particles are also circulated from the gastrointestinal tract to the liver and onward to the gall bladder, presumably for final transport back to the gastrointestinal tract.
引用
收藏
页码:1764 / 1774
页数:11
相关论文
共 31 条
[1]
Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N [J].
BernkopSchnurch, A ;
Paikl, C ;
Valenta, C .
PHARMACEUTICAL RESEARCH, 1997, 14 (07) :917-922
[2]
Influence of molecular weight on oral absorption of water soluble chitosans [J].
Chae, SY ;
Jang, MK ;
Nah, JW .
JOURNAL OF CONTROLLED RELEASE, 2005, 102 (02) :383-394
[3]
D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74
[4]
RANITIDINE BIOAVAILABILITY AND KINETICS IN NORMAL-MALE SUBJECTS [J].
GARG, DC ;
WEIDLER, DJ ;
ESHELMAN, FN .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (04) :445-452
[5]
Label-free imaging of polymeric nanomedicines using coherent anti-stokes Raman scattering microscopy [J].
Garrett, N. L. ;
Lalatsa, A. ;
Begley, D. ;
Mihoreanu, L. ;
Uchegbu, I. F. ;
Schoetzlein, A. G. ;
Moger, J. .
JOURNAL OF RAMAN SPECTROSCOPY, 2012, 43 (05) :681-688
[6]
Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy [J].
Garrett, Natalie Laura ;
Lalatsa, Aikaterini ;
Uchegbu, Ijeoma ;
Schaetzlein, Andreas ;
Moger, Julian .
JOURNAL OF BIOPHOTONICS, 2012, 5 (5-6) :458-468
[7]
HUSSAIN MA, 1990, DRUG METAB DISPOS, V18, P288
[8]
Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics [J].
Hussain, N ;
Jaitley, V ;
Florence, AT .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 (1-2) :107-142
[9]
DESOLVATION ENERGY - A MAJOR DETERMINANT OF ABSORPTION, BUT NOT CLEARANCE, OF PEPTIDES IN RATS [J].
KARLS, MS ;
RUSH, BD ;
WILKINSON, KF ;
VIDMAR, TJ ;
BURTON, PS ;
RUWART, MJ .
PHARMACEUTICAL RESEARCH, 1991, 8 (12) :1477-1481
[10]
Structure, depolymerization, and cytocompatibility evaluation of glycol chitosan [J].
Knight, Darryl K. ;
Shapka, Stephen N. ;
Amsden, Brian G. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2007, 83A (03) :787-798